.jpg)
HONG KONG, May 29 (Bernama-BUSINESS WIRE) -- Coupling with the first Nikkei 225 Index ETF (3153.HK) in Hong Kong, CSOP Asset Management Limited (“CSOP Asset Management”) rolls out CSOP Nikkei 225 Daily (2x) Leveraged Product (7262.HK) and CSOP Nikkei 225 Daily (-2x) Inverse Product (7515.HK), which will be listed on Hong Kong Stock Exchange on May 29, 2024 as the world’s first pair of Nikkei 225 Leveraged & Inverse Products (L&Is) outside of Japan1. Aligning with CSOP Nikkei 225 Index ETF (3153.HK), which was launched to help investors tap into the long-term investment value in Japan, 7262.HK and 7515.HK aim to help investors ride on the short-term ebb and flow of Japan market.
This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20240528817965/en/
This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20240528817965/en/
In order to track the two times daily performance and two times inverse of the daily performance (before fees and expenses) of the Nikkei 225 Index, both 7262.HK and 7515.HK deploy a futures-based replication strategy, through investing directly in the nearest quarter Nikkei 225 Futures (and/or nearest quarter Nikkei 225 mini), with a listing price of about 78 Hong Kong dollars per unit, trading lot of 10, and management fee of 1.6% of the ETF’s net asset value per year. 7262.HK and 7515.HK each has received an initial investment of around 10 million US dollars.
The Nikkei 225 Index has surged by 17.77% YTD after rising 30% in 2023, positioning Japan as the best performing stock market among major global markets2. The launch of the Leveraged and Inverse Products is in response to mixed views on the outlook of Japan stock market after it hit the all-time high. On one hand, the corporate efforts to enhance ROE and shareholder returns continue to bolster valuations. The Bank of Japan maintains accommodative monetary policy this year, and the inflation outlook remains steady3. On the other hand, Japanese Yen, reached its 34-year nadir lately4, is deterring foreign investors from Japanese stocks, while weak domestic consumption has led to tepid economic growth. Additionally, Japan has lost its crown as the world’s third-largest economy in Q4 2023, with GDP figures disappointed5.
Among the top 10 actively traded ETPs, 6 are Leveraged and Inverse Products of the Nikkei 225 Index, establishing them the most actively traded ETPs in Japan6. 7262.HK and 7515.HK provide additional tools for Hong Kong investors seeking to capture the fluctuations in the Japanese market. Nikkei 225 Futures and Nikkei 225 mini are futures contracts on the Nikkei Stock Average, traded on the Osaka Exchange (OSE). These futures are the most popular ones in Japan, accounting for approximately 70% of the total derivatives market, with foreign investors making up around 75%7.
Ms. Ding Chen, CEO of CSOP Asset Management Limited, is delighted to announce the listing of the CSOP Nikkei 225 Daily (2x) Leveraged Product (7262.HK) and CSOP Nikkei 225 Daily (-2x) Inverse Product (7515.HK) on the Hong Kong Stock Exchange tomorrow. She remarks, "As an ETF issuer esteemed by investors in the APAC region, CSOP has consistently endeavored to offer comprehensive and diversified investment products. Currently, we stand as the leading issuer of Leveraged and Inverse products in Hong Kong, commanding a market share of 99%8. The introduction of the first Nikkei 225 Index L&Is listed in Hong Kong presents avenues for capturing short-term opportunities in the Japanese market."
About CSOP:
CSOP is a leading ETF issuer in Hong Kong SAR, with a wide range of product offerings across equity, fixed income, leveraged and inverse, thematic, money market, and virtual assets. In 2023, 5 out of 10 of the most traded ETFs on the Hong Kong Stock Exchange are CSOP-issued products*. Innovation and leadership are deeply rooted in CSOP’s DNA as we strive to bring first-of-its-kind products to the market, educate investors about ETF trading, and never stop looking for ways to improve trading efficiencies.
CSOP’s commitment to cross-border initiatives and collaborations is unwavering. We are the only product issuer participating in all the ETF connectivity programs between mainland China and Hong Kong SAR, capturing an 89% market share of the aggregate southbound AUM**, as well as the first issuer to participate in the China – Singapore Cross-border ETF Link Scheme.
* Source: Daily average from 1 January 2023 to 31 December 2023, Bloomberg
** Source: As of 28 September 2023, 89% of southbound connect total AUM is from CSOP Hang Seng TECH Index ETF and CSOP Hang Seng Index ETF, CSOP
The Nikkei 225 Index has surged by 17.77% YTD after rising 30% in 2023, positioning Japan as the best performing stock market among major global markets2. The launch of the Leveraged and Inverse Products is in response to mixed views on the outlook of Japan stock market after it hit the all-time high. On one hand, the corporate efforts to enhance ROE and shareholder returns continue to bolster valuations. The Bank of Japan maintains accommodative monetary policy this year, and the inflation outlook remains steady3. On the other hand, Japanese Yen, reached its 34-year nadir lately4, is deterring foreign investors from Japanese stocks, while weak domestic consumption has led to tepid economic growth. Additionally, Japan has lost its crown as the world’s third-largest economy in Q4 2023, with GDP figures disappointed5.
Among the top 10 actively traded ETPs, 6 are Leveraged and Inverse Products of the Nikkei 225 Index, establishing them the most actively traded ETPs in Japan6. 7262.HK and 7515.HK provide additional tools for Hong Kong investors seeking to capture the fluctuations in the Japanese market. Nikkei 225 Futures and Nikkei 225 mini are futures contracts on the Nikkei Stock Average, traded on the Osaka Exchange (OSE). These futures are the most popular ones in Japan, accounting for approximately 70% of the total derivatives market, with foreign investors making up around 75%7.
Ms. Ding Chen, CEO of CSOP Asset Management Limited, is delighted to announce the listing of the CSOP Nikkei 225 Daily (2x) Leveraged Product (7262.HK) and CSOP Nikkei 225 Daily (-2x) Inverse Product (7515.HK) on the Hong Kong Stock Exchange tomorrow. She remarks, "As an ETF issuer esteemed by investors in the APAC region, CSOP has consistently endeavored to offer comprehensive and diversified investment products. Currently, we stand as the leading issuer of Leveraged and Inverse products in Hong Kong, commanding a market share of 99%8. The introduction of the first Nikkei 225 Index L&Is listed in Hong Kong presents avenues for capturing short-term opportunities in the Japanese market."
About CSOP:
CSOP is a leading ETF issuer in Hong Kong SAR, with a wide range of product offerings across equity, fixed income, leveraged and inverse, thematic, money market, and virtual assets. In 2023, 5 out of 10 of the most traded ETFs on the Hong Kong Stock Exchange are CSOP-issued products*. Innovation and leadership are deeply rooted in CSOP’s DNA as we strive to bring first-of-its-kind products to the market, educate investors about ETF trading, and never stop looking for ways to improve trading efficiencies.
CSOP’s commitment to cross-border initiatives and collaborations is unwavering. We are the only product issuer participating in all the ETF connectivity programs between mainland China and Hong Kong SAR, capturing an 89% market share of the aggregate southbound AUM**, as well as the first issuer to participate in the China – Singapore Cross-border ETF Link Scheme.
* Source: Daily average from 1 January 2023 to 31 December 2023, Bloomberg
** Source: As of 28 September 2023, 89% of southbound connect total AUM is from CSOP Hang Seng TECH Index ETF and CSOP Hang Seng Index ETF, CSOP
http://mrem.bernama.com/viewsm.php?idm=48687
No comments:
Post a Comment